TytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round to Scale AI-First Clinical Enablement Platform
Summary
TytoCare named Adam Pellegrini as its new CEO and closed a $25 million-plus growth round led by Insight Partners. The company said it will use the capital to expand its AI clinical algorithms, deepen payer and health system partnerships, and speed go-to-market efforts. TytoCare also added Greg Orr as COO as it pushes a clinical enablement model for virtual primary care, cardiopulmonary monitoring, and oncology support. The company plans to embed its FDA-cleared devices and AI-powered software into care workflows for health systems, payers, and employer health programs.
Funding
Amount
$25.0M
Total raised
Date
July 15, 2026
Announcement date
Investors
Insight Partners, Qumra Capital, Echo Health Ventures, Olive Tree Ventures, Qualcomm Ventures, OrbiMed, West Fountain Global Fund
Lead investors
Company
https://www.tytocare.com
Funded company
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
SaaS
Digital Health
Telehealth Software
Linked Companies
TytoCare
$10M to $25M